Abstract:Aim/hypothesis Growth/differentiation factor 15 (GDF15) is a therapeutic target for a variety of metabolic diseases, including type 1 diabetes (T1D). However, the nausea caused by GDF15 is a challenging point for therapeutic development. In addition, it is unknown why the endogenous GDF15 fails to protect from T1D development. Here, we investigate the GDF15 signaling in pancreatic islets towards opening possibilities for therapeutic targeting in beta cells and to understand why this protection fails to occur naturally. Methods GDF15 signaling in islets was determined by proximity-ligation assay, untargeted proteomics, pathway analysis, and treatment of cells with specific inhibitors. To determine if GDF15 levels would increase prior to disease onset, plasma levels of GDF15 were measured in a longitudinal prospective study of children during T1D development (n=132 cases vs. n=40 controls) and in children with islet autoimmunity but normoglycemia (n=47 cases vs. n=40 controls) using targeted mass spectrometry. We also investigated the regulation of GDF15 production in islets by fluorescence microscopy and western blot analysis. Results The proximity-ligation assay identified ERBB2 as the GDF15 receptor in islets, which was confirmed using its specific antagonist, tucatinib. The untargeted proteomics analysis and caspase assay showed that ERBB2 activation by GDF15 reduces beta cell apoptosis by downregulating caspase 8. In plasma, GDF15 levels were higher (p=0.0024) during T1D development compared to controls, but not in islet autoimmunity with normoglycemia. However, in the pancreatic islets GDF15 was depleted via sequestration of its mRNA into stress granules, resulting in translation halting. Conclusions/interpretation GDF15 protects against T1D via ERBB2-mediated decrease of caspase 8 expression in pancreatic islets. Circulating levels of GDF15 increases pre-T1D onset, which is insufficient to promote protection due to its localized depletion in the islets. These findings open opportunities for targeting GDF15 downstream signaling for pancreatic beta-cell protection in T1D and help to explain the lack of natural protection by the endogenous protein.

LGR4 is essential for maintaining beta-cell homeostasis through suppression of RANK

LGR4 is essential for maintaining β-cell homeostasis through suppression of RANK

GRP94 is an IGF-1R chaperone and regulates beta cell death in diabetes

Aberrant activation of liver X receptors impairs pancreatic beta cell function through upregulation of sterol regulatory element-binding protein 1c in mouse islets and rodent cell lines

Heterogeneous Development of Β-Cell Populations in Diabetes-Resistant and Susceptible Mice

MicroRNA-223 is Essential for Maintaining Functional Β-Cell Mass During Diabetes Through Inhibiting Both FOXO1 and SOX6 Pathways

Targeted Pharmacological Therapy Restores Beta-Cell Function For Diabetes Remission

Lactogens Reduce Endoplasmic Reticulum Stress–Induced Rodent and Human β-Cell Death and Diabetes Incidence in Akita Mice

NR4A1 counteracts JNK activation incurred by ER stress or ROS in pancreatic -cells for protection

Intracellular lipid metabolism impairs β cell compensation during diet-induced obesity.

Renalase inhibition regulates β cell metabolism to defend against acute and chronic stress

Disruption of Growth Factor Receptor–Binding Protein 10 in the Pancreas Enhances Β-Cell Proliferation and Protects Mice from Streptozotocin-Induced Β-Cell Apoptosis

Retinol-Binding Protein 4 Activates Stra6, Provoking Pancreatic Beta-Cell Dysfunction In Type 2 Diabetes

GRB10 Regulates Β-Cell Mass by Inhibiting Β-Cell Proliferation and Stimulating Β-Cell Dedifferentiation

Protection of beta cells against pro-inflammatory cytokine stress by the GDF15-ERBB2 signaling

VGLL4 and MENIN Function As TEAD1 Corepressors to Block Pancreatic Β Cell Proliferation

2142-P: Toll-Like Receptors 2 and 4 Act As Brakes to Regulate Adaptive SS-Cell Mass Expansion in Diet-Induced Obesity

203-OR: VGLL4 and MENIN Function As TEAD1 Corepressors to Block Pancreatic SS-Cell Proliferation

Protective Action of Liraglutide in Beta Cells Under Lipotoxic Stress Via PI3K/Akt/FoxO1 Pathway

Retinol-Binding Protein 4 Activates STRA6 Provoking Pancreatic β Cell Dysfunction in Type 2 Diabetes

Beta-cell adaptation to metabolic stresses requires prolactin receptor signaling